Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > NVE Corporation Reports Third Quarter Results

Abstract:
NVE Corporation (Nasdaq:NVEC) announced today financial results for the quarter and nine months ended December 31, 2007.

NVE Corporation Reports Third Quarter Results

EDEN PRAIRIE, MN | Posted on January 23rd, 2008

Product sales for the quarter increased 25% over the prior-year quarter to $4.25 million from $3.40 million. Total revenue, consisting of product sales and contract research and development revenue, increased 23% to $4.77 million for the third quarter of fiscal 2008 from $3.86 million in the prior-year quarter. Net income for the third quarter of fiscal 2008 increased 62% to $1.70 million, or $0.36 per diluted share, compared to $1.05 million, or $0.22 per share, for the prior-year quarter.

For the first nine months of fiscal 2008, product sales increased 25% to $12.83 million from $10.23 million for the first nine months of fiscal 2007. Total revenue increased 22% to $14.48 million for the first nine months of fiscal 2008 from $11.90 million for the prior-year period. Net income for the nine months of fiscal 2008 was $4.93 million, or $1.04 per diluted share compared to $3.23 million, or $0.67 per diluted share, for the first nine months of fiscal 2007.

"We are pleased to report our best third quarter ever," said NVE President and Chief Executive Officer Daniel A. Baker, Ph.D. "Increases in product sales and operating margins drove record earnings."

####

About NVE Corporation

NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. NVE has also licensed its spintronic magnetoresistive random access memory technology, commonly known as MRAM.

Statements used in this press release that relate to future plans, events, financial results or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as risks in continued growth in revenue and profitability, risks associated with our reliance on several large customers, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K and other reports filed with the SEC.


                           NVE CORPORATION
                         STATEMENTS OF INCOME
 QUARTERS AND NINE MONTHS ENDED DECEMBER 31, 2007 AND 2006 (Unaudited)

                                            Quarter Ended December 31
                                              2007             2006
                                           -----------     -----------
 Revenue
  Product sales                            $ 4,249,809     $ 3,402,937
  Contract research and
   development                                 515,716         459,112
                                           -----------     -----------
 Total revenue                               4,765,525       3,862,049
 Cost of sales                               1,663,045       1,385,163
                                           -----------     -----------
 Gross profit                                3,102,480       2,476,886
 Expenses
  Selling, general, and
   administrative                              492,771         479,387
  Research and development                     347,344         544,779
                                           -----------     -----------
 Total expenses                                840,115       1,024,166
                                           -----------     -----------
 Income from operations                      2,262,365       1,452,720
 Interest income                               259,865         157,337
 Other income                                   62,930             --
                                           -----------     -----------
 Income before taxes                         2,585,160       1,610,057
 Provision for income taxes                    882,867         558,504
                                           -----------     -----------
 Net income                                $ 1,702,293     $ 1,051,553
                                           ===========     ===========
 Net income per share - basic              $      0.37     $      0.23
                                           ===========     ===========
 Net income per share - diluted            $      0.36     $      0.22
                                           ===========     ===========
 Weighted average shares outstanding
  Basic                                      4,637,275       4,620,835
  Diluted                                    4,764,430       4,786,868
 Supplemental financial data
  Stock-based compensation                 $     5,598     $     8,167
  Cash paid for income taxes               $   725,000     $      --

                                            Nine Months Ended Dec. 31
                                               2007            2006
                                           -----------     -----------
 Revenue
  Product sales                            $12,830,771     $10,233,325
  Contract research and
   development                               1,648,657       1,662,287
                                           -----------     -----------
 Total revenue                              14,479,428      11,895,612
 Cost of sales                               4,956,973       4,224,165
                                           -----------     -----------
 Gross profit                                9,522,455       7,671,447
 Expenses
  Selling, general,
   and administrative                        1,631,936       1,421,332
  Research and development                   1,169,018       1,641,637
                                           -----------     -----------
 Total expenses                              2,800,954       3,062,969
                                           -----------     -----------
 Income from operations                      6,721,501       4,608,478
 Interest income                               731,243         418,683
 Interest expense                                   --            (589)
 Other income                                   62,930          25,246
                                           -----------     -----------
 Income before taxes                         7,515,674       5,051,818
 Provision for income taxes                  2,581,272       1,824,988
                                           -----------     -----------
 Net income                                $ 4,934,402     $ 3,226,830
                                           ===========     ===========
 Net income per share - basic              $      1.06     $      0.70
                                           ===========     ===========
 Net income per share - diluted            $      1.04     $      0.67
                                           ===========     ===========
 Weighted average shares
  outstanding
  Basic                                      4,634,102       4,618,086
  Diluted                                    4,761,112       4,784,118
 Supplemental financial data
  Stock-based compensation                 $   164,008     $   128,203
  Cash paid for income taxes               $ 2,209,313     $    44,300


                           NVE CORPORATION
                            BALANCE SHEETS
                    DECEMBER 31 AND MARCH 31, 2007

                                          (Unaudited)
                                            Dec. 31,       March 31,
                                              2007            2007
                                         -------------   -------------
 ASSETS
 Current assets
   Cash and cash
    equivalents                            $ 1,251,701       $ 397,423
   Marketable securities,
    short term                               1,693,149         982,415
   Accounts receivable,
     net of allowance for
     uncollectible accounts
     of $15,000                              2,182,762       2,005,005
   Inventories                               2,493,812       2,016,858
   Deferred tax assets                         473,289       1,328,106
   Prepaid expenses and
    other assets                               839,037         333,587
                                         -------------   -------------
 Total current assets                        8,933,750       7,063,394
 Fixed assets
   Machinery and equipment                   5,061,407       4,458,948
   Leasehold improvements                      436,794         413,482
                                         -------------   -------------
                                             5,498,201       4,872,430
   Less accumulated
    depreciation                             4,173,394       3,834,683
                                         -------------   -------------
 Net fixed assets                            1,324,807       1,037,747
 Marketable securities,
  long term                                 20,109,098      16,909,353
                                         -------------   -------------
 Total assets                             $ 30,367,655    $ 25,010,494
                                         =============   =============

 LIABILITIES AND SHAREHOLDERS' EQUITY
 Current liabilities
   Accounts payable                       $    435,175    $    502,595
   Accrued payroll and other                   550,276         590,287
   Deferred revenue                            237,101          29,357
                                         -------------   -------------
 Total current liabilities                   1,222,552       1,122,239

 Shareholders' equity
   Common stock                                 46,387          46,274
   Additional paid-in capital               18,533,940      18,289,248
   Accumulated other
    comprehensive loss                          (6,641)        (84,282)
   Retained earnings                        10,571,417       5,637,015
                                         -------------   -------------
 Total shareholders' equity                 29,145,103      23,888,255
                                         -------------   -------------
 Total liabilities and
  shareholders' equity                    $ 30,367,655    $ 25,010,494
                                         =============   =============

For more information, please click here

Contacts:
NVE Corporation
Curt A. Reynders, CFO
(952) 829-9217

Copyright © PrimeNewswire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Spintronics

Researchers discover a potential application of unwanted electronic noise in semiconductors: Random telegraph noises in vanadium-doped tungsten diselenide can be tuned with voltage polarity August 11th, 2023

Quantum materials: Electron spin measured for the first time June 9th, 2023

Rensselaer researcher uses artificial intelligence to discover new materials for advanced computing Trevor Rhone uses AI to identify two-dimensional van der Waals magnets May 12th, 2023

Spin photonics to move forward with new anapole probe November 4th, 2022

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project